Literature DB >> 7846043

Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy.

A M Moudy1, S D Handran, M P Goldberg, N Ruffin, I Karl, P Kranz-Eble, D C DeVivo, S M Rothman.   

Abstract

Patients with several inherited human encephalomyopathies exhibit systemic and neurological symptoms in association with specific mitochondrial mutations. The mechanisms by which these mitochondrial mutations result in cellular injury have not been elucidated. One potential cause of neuronal vulnerability is an inability to effectively buffer intracellular calcium. We report that fibroblasts from patients with one specific inherited encephalomyopathy, MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) syndrome, have elevated levels of ionized calcium and cannot normally sequester calcium influxes. Quantitative fluorescence imaging demonstrated that this abnormality was associated with a relative decrease in mitochondrial membrane potential compared to control fibroblasts. This documentation of pathological calcium homeostasis in a genetic neurological disease extends the calcium hypothesis of toxic cell injury to human mitochondrial encephalomyopathies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7846043      PMCID: PMC42693          DOI: 10.1073/pnas.92.3.729

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation.

Authors:  Y Goto; S Horai; T Matsuoka; Y Koga; K Nihei; M Kobayashi; I Nonaka
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

2.  Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1.

Authors:  S T Smiley; M Reers; C Mottola-Hartshorn; M Lin; A Chen; T W Smith; G D Steele; L B Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 3.  Neurological disease and mitochondrial genes.

Authors:  A E Harding
Journal:  Trends Neurosci       Date:  1991-04       Impact factor: 13.837

4.  A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Biochim Biophys Acta       Date:  1991-10-21

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

7.  Mitochondrial genetics: a paradigm for aging and degenerative diseases?

Authors:  D C Wallace
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

Review 8.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Authors:  M F Beal
Journal:  Ann Neurol       Date:  1992-02       Impact factor: 10.422

Review 9.  Alternative excitotoxic hypotheses.

Authors:  R L Albin; J T Greenamyre
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

Review 10.  Correlative multidisciplinary approach to the study of mitochondrial encephalomyopathies.

Authors:  G Karpati; D Arnold; P Matthews; S Carpenter; F Andermann; E Shoubridge
Journal:  Rev Neurol (Paris)       Date:  1991       Impact factor: 2.607

View more
  19 in total

1.  Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure.

Authors:  R J White; I J Reynolds
Journal:  J Neurosci       Date:  1996-09-15       Impact factor: 6.167

2.  Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production.

Authors:  J N Keller; Q Guo; F W Holtsberg; A J Bruce-Keller; M P Mattson
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

3.  Mitochondrial DNA mutations affect calcium handling in differentiated neurons.

Authors:  Andrew J Trevelyan; Denise M Kirby; Tora K Smulders-Srinivasan; Marco Nooteboom; Rebeca Acin-Perez; José Antonio Enriquez; Miles A Whittington; Robert N Lightowlers; Doug M Turnbull
Journal:  Brain       Date:  2010-03-05       Impact factor: 13.501

Review 4.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Mitochondrial membrane potential probes and the proton gradient: a practical usage guide.

Authors:  Seth W Perry; John P Norman; Justin Barbieri; Edward B Brown; Harris A Gelbard
Journal:  Biotechniques       Date:  2011-02       Impact factor: 1.993

6.  Impaired Bioenergetics in Mutant Mitochondrial DNA Determines Cell Fate During Seizure-Like Activity.

Authors:  Stjepana Kovac; Elisavet Preza; Henry Houlden; Matthew C Walker; Andrey Y Abramov
Journal:  Mol Neurobiol       Date:  2018-04-27       Impact factor: 5.590

7.  Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells.

Authors:  Fimmie Reinecke; Oksana Levanets; Yolanda Olivier; Roan Louw; Boitumelo Semete; Anne Grobler; Juan Hidalgo; Jan Smeitink; Antonel Olckers; Francois H Van der Westhuizen
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

8.  Decreased hippocampal expression of calbindin D28K and cognitive impairment in MELAS.

Authors:  Valentina Emmanuele; Angels Garcia-Cazorla; Hua-Bin Huang; Jorida Coku; Beatriz Dorado; Etty P Cortes; Kristin Engelstad; Darryl C De Vivo; Salvatore Dimauro; Eduardo Bonilla; Kurenai Tanji
Journal:  J Neurol Sci       Date:  2012-04-05       Impact factor: 3.181

9.  Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations.

Authors:  A M James; Y H Wei; C Y Pang; M P Murphy
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

10.  beta-Glucan enhanced apoptosis in human colon cancer cells SNU-C4.

Authors:  Mi-Ja Kim; Se-Young Hong; Sun-Kyu Kim; Chul Cheong; Hong-Ju Park; Hye-Kyung Chun; Ki-Hyo Jang; Byung-Dae Yoon; Chul-Ho Kim; Soon Ah Kang
Journal:  Nutr Res Pract       Date:  2009-09-30       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.